Signostics Inc., a developer of palm-sized ultrasound devices for medical applications, has raised $5 million in new VC funding. No investor information was disclosed. The company previously raised $14 million from firms that included Brandon Capital Partners, Playford Capital and Terra Rossa Capital. It has offices in Australia and Silicon Valley.
2 min read · 31 March 2010
Boehringer Ingelheim, a German pharmaceutical company, has launched a €100 million corporate venture fund. The vehicle will invest in startups "that provide ground-breaking therapeutic approaches and technologies to help drive innovation in medical science. "
2 min read · 31 March 2010
1 min read · 31 March 2010
1 min read · 31 March 2010
1 min read · 31 March 2010
Damballa Inc., an Atlanta-based developer of Internet security software focused on "bot armies," has raised an undisclosed amount of Series C funding from GRA Venture Fund. It previously raised $8.5 million from InterWest Partners, Noro-Moseley Partners and Sigma Partners.
3 min read · 30 March 2010
Reverse Medical Corp., an Irvine, Calif.-based developer of technologies for treating acute ischemic strokes, has raised $14 million in Series B funding. New backers included Wexford Capital, Getz Bros., BioStar Ventures, Early Stage Partners and Emergent Medical Partners. Return backers included NBGI Ventures, MedFocus Funds and South Australian Life Science Advancement Partnership.
2 min read · 30 March 2010
MuleSoft, a San Francisco-based provider of Internet infrastructure software, support and services, has raised $12 million in third-round funding. SAP Ventures led the round, and was joined by Bay Partners and return backers Hummer Winblad Venture Partners, Morgenthaler Ventures and Lightspeed Venture Partners.
3 min read · 30 March 2010
Derivix, a New York-based provider of pricing and analytics solutions to the options trading market, has raised an undisclosed amount of new funding from J.P. Morgan and S.A.C. Venture Investments. The company previously raised $6.7 million in Series A funding from Goldman Sachs and Susquehanna Growth Equity.
3 min read · 30 March 2010
JenaValve, a German maker of aortic valves, has raised €19 million in Series B funding. Backers include GIMV, Atlas Venture, Edmond de Rothschild Investment Partners, Neomed Management, VI Partners and Sunstone Capital.
2 min read · 30 March 2010
